首页> 外文OA文献 >The AOSpine North America Geriatric Odontoid Fracture Mortality Study: A Retrospective Review of Mortality Outcomes for Operative Versus Nonoperative Treatment of 322 Patients With Long-Term Follow-up.
【2h】

The AOSpine North America Geriatric Odontoid Fracture Mortality Study: A Retrospective Review of Mortality Outcomes for Operative Versus Nonoperative Treatment of 322 Patients With Long-Term Follow-up.

机译:aOspine北美老年齿状突骨折死亡率研究:回顾性分析322例长期随访患者的手术与非手术治疗的死亡率结果。

摘要

STUDY DESIGN.: Retrospective, multicenter cohort study. OBJECTIVE.: Assess for differences in short- and long-term mortality between operative and nonoperative treatment for elderly patients with type II odontoid fractures. SUMMARY OF BACKGROUND DATA.: There is controversy regarding whether operative or nonoperative management is the best treatment for elderly patients with type II odontoid fractures. METHODS.: This is a retrospective study of consecutive patients aged 65 years or older with type II odontoid fracture from 3 level I trauma centers from 2003-2009. Demographics, comorbidities, and treatment were abstracted from medical records. Mortality outcomes were obtained from medical records and a public database. Hazard ratios (HRs) and 95% confidence intervals (CI) were calculated. RESULTS.: A total of 322 patients were included (mean age, 81.8 yr; range, 65.0-101.5 yr). Compared with patients treated nonoperatively (n = 157), patients treated operatively (n = 165) were slightly younger (80.4 vs. 83.2 yr, P = 0.0014), had a longer hospital (15.0 vs. 7.4 d, P u3c 0.001) and intensive care unit (1.5 vs. 1.1 d, P = 0.008) stay, and were more likely to receive a feeding tube (18% vs. 5%, P = 0.0003). Operative and nonoperative treatment groups had similar sex distribution (P = 0.94) and Charlson comorbidity index (P = 0.11). Within 30 days of presentation, 14% of patients died, and at maximal follow-up (average = 2.05 yr; range = 0 d-7.02 yr), 44% had died. On multivariate analysis, nonoperative treatment was associated with higher 30-day mortality (HR = 3.00, 95% CI = 1.51-5.94, P = 0.0017), after adjusting for age (HR = 1.10, 95% CI = 1.05-1.14; P u3c 0.0001), male sex (P = 0.69), and Charlson comorbidity index (P = 0.16). At maximal follow-up, there was a trend toward higher mortality associated with nonoperative treatment (HR = 1.35, 95% CI = 0.97-1.89, P = 0.079), after adjusting for age (HR = 1.07, 95% CI = 1.05-1.10; P u3c 0.0001), male sex (HR = 1.55, 95% CI = 1.10-2.16; P = 0.012), and Charlson comorbidity index (HR = 1.28, 95% CI = 1.16-1.40; P u3c 0.0001). CONCLUSION.: Surgical treatment of type II odontoid fracture in this elderly population did not negatively impact survival, even after adjusting for age, sex, and comorbidities. The data suggest a significant 30-day survival advantage and a trend toward improved longer-term survival for operatively treated over nonoperatively treated patients.Level of Evidence: 4.
机译:研究设计::回顾性,多中心队列研究。目的:评估老年II型齿状突骨折患者手术与非手术治疗之间短期和长期死亡率的差异。背景数据摘要:对于老年II型齿状突骨折患者,手术或非手术治疗是否是最佳治疗尚存在争议。方法:这是一项回顾性研究,研究对象是2003-2009年来自3个I级创伤中心的连续65岁或65岁以上的II型齿突类骨折患者。人口统计学,合并症和治疗是从病历中提取的。死亡率结果来自病历和公共数据库。计算危害比(HRs)和95%置信区间(CI)。结果:共纳入322例患者(平均年龄81.8岁;范围65.0-101.5岁)。与非手术治疗的患者(n = 157)相比,手术治疗的患者(n = 165)年龄稍小(80.4 vs. 83.2 yr,P = 0.0014),住院时间更长(15.0 vs. 7.4 d,P <0.001)和重症监护病房(1.5 vs. 1.1 d,P = 0.008)停留,并且更有可能接受饲管(18%vs. 5%,P = 0.0003)。手术和非手术治疗组的性别分布(P = 0.94)和查尔森合并症指数(P = 0.11)相似。在就诊后30天内,有14%的患者死亡,并且在最大随访时间(平均= 2.05年;范围= 0 d-7.02年),有44%的患者死亡。在多因素分析中,调整年龄后(HR = 1.10,95%CI = 1.05-1.14; P值),非手术治疗的30天死亡率较高(HR = 3.00,95%CI = 1.51-5.94,P = 0.0017)。 u3c 0.0001),男性(P = 0.69)和查尔森合并症指数(P = 0.16)。在进行最大随访后,调整年龄后(HR = 1.07,95%CI = 1.05-),与非手术治疗相关的死亡率有增加的趋势(HR = 1.35,95%CI = 0.97-1.89,P = 0.079)。 1.10; P u3c 0.0001),男性(HR = 1.55,95%CI = 1.10-2.16; P = 0.012)和查尔森合并症指数(HR = 1.28,95%CI = 1.16-1.40; P u3c 0.0001) 。结论:即使在调整了年龄,性别和合并症之后,该老年人群的II型齿状突骨折的手术治疗也没有负面影响生存。数据表明,与未接受手术治疗的患者相比,接受手术治疗的患者具有30天的明显生存优势以及长期生存率有改善的趋势。证据水平:4。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号